J M Smith Corporation

Merz Pharmaceuticals is a specialty pharmaceutical firm that develops health care solutions for unmet medical needs. Its German-based research efforts consist of product development for the treatment of central nervous system disorders, as well as over-the-counter medications for illness prevention and health preservation. The company features the Naftin, Appearex, Mederma and Aqua Glycolic brands. Naftifine hydrochloride has been shown to exhibit fungicidal activity in vitro against a broad spectrum of organisms. Appearex stimulates healthy nail growth, smoothes brittle ridges and increases nail strength. Mederma is among the leading products for treating new and existing scars. It softens and smoothens scars that result from surgery, accidents, injuries, burns, acne and stretch marks. The Aqua Glycolic line of products is pH balanced to minimize irritation and includes facial cleanser, toner, face cream, shampoos and body lotion. Merz Pharmaceuticals also produces Erygel, Eldertonic, Eldercaps and Sedapap. The company was founded in 1908 and is based in Greensboro, N.C.

Collaborations Pharmaceuticals, Inc is a drug discovery company based in Raleigh, NC, specializing in rare and neglected diseases. They utilize cutting-edge software and machine learning technologies to develop innovative solutions for a wide range of diseases, including Ebola, HIV, COVID-19, Alzheimer's disease, and cancer. With a team of experienced scientists and a strong focus on collaboration and partnerships, Collaborations Pharmaceuticals is dedicated to making significant advancements in the field of drug discovery and providing effective treatments for diseases that have been historically overlooked.Generated from the website

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that treat cancer, cardiovascular and autoimmune diseases and viral infections. BioCryst uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry and computer modeling. In structure-based drug design, scientists use detailed knowledge of the active sites of protein targets associated with particular diseases to design synthetic compounds that fight the disease. Structure-based drug design aims to create a molecule that will bind to the active site of a targeted enzyme, thereby preventing the normal chemical reaction and ultimately halting the progression of the disease. BioCryst was founded in 1986. The Company's stock is traded on the NASDAQ exchange under the symbol BCRX.